Baeuerle, Patrick A.
Micromet, 81477 Munich, Germany; and · Micromet, Bethesda, MD 20817
21 papers on CoChatORCID 0009-0006-7117-2784
Most cited papers
- Verified
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology
NF-κB Signaling PathwaysImmune Response and Inflammation
Cited by 4,745
- Verified
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine
NF-κB Signaling PathwaysImmune Response and Inflammation
Cited by 1,508
- Verified
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
Bargou, R., Leo, E., Zugmaier, G., Klinger, M., Goebeler, M., Knop, S., Noppeney, R., Viardot, A., Hess, G., Schuler, M., et al. (2008) · Science
Monoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy research
Cited by 1,078
- Verified
Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb
Janssen-Heininger, Y. M. W., Poynter, M. E., & Baeuerle, P. A. (2000) · Free Radical Biology and Medicine
NF-κB Signaling PathwaysRedox biology and oxidative stress
Cited by 666
- Verified
Bispecific T-Cell Engaging Antibodies for Cancer Therapy
Baeuerle, P. A., & Reinhardt, C. (2009) · Cancer Research
Monoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy research
Cited by 592
- Verified
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Munz, M., Baeuerle, P. A., & Gires, O. (2009) · Cancer Research
Cancer Cells and MetastasisWnt/β-catenin signaling in development and cancer
Cited by 515
- Verified
Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells
Offner, S., Hofmeister, R., Romaniuk, A., Kufer, P., & Baeuerle, P. A. (2006) · Molecular Immunology
Monoclonal and Polyclonal Antibodies ResearchT-cell and B-cell Immunology
Cited by 365
- Verified
Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct
Hoffmann, P., Hofmeister, R., Brischwein, K., Brandl, C., Crommer, S., Bargou, R., Itin, C., Prang, N., & Baeuerle, P. A. (2005) · International Journal of Cancer
Monoclonal and Polyclonal Antibodies ResearchT-cell and B-cell Immunology
Cited by 344
- Verified
DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition
Zabel, U., Schreck, R., & Baeuerle, P. A. (1991) · Journal of Biological Chemistry
NF-κB Signaling PathwaysGenomics and Chromatin Dynamics
Cited by 344
- Verified
BiTEs: bispecific antibody constructs with unique anti-tumor activity
Wolf, E., Hofmeister, R., Kufer, P., Schlereth, B., & Baeuerle, P. A. (2005) · Drug Discovery Today
Monoclonal and Polyclonal Antibodies ResearchToxin Mechanisms and Immunotoxins
Cited by 260
- Verified
MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors
Brischwein, K., Schlereth, B., Guller, B., Steiger, C., Wolf, A., Lutterbuese, R., Offner, S., Locher, M., Urbig, T., Raum, T., et al. (2006) · Molecular Immunology
Monoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses
Cited by 256
- Verified
T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct
Dreier, T., Baeuerle, P. A., Fichtner, I., Grün, M., Schlereth, B., Lorenczewski, G., Kufer, P., Lutterbüse, R., Riethmüller, G., Gjorstrup, P., et al. (2003) · The Journal of Immunology
Monoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy research
Cited by 191
- Verified
Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid
Camandola, S., Leonarduzzi, G., Musso, T., Varesio, L., Carini, R., Scavazza, A., Chiarpotto, E., Baeuerle, P. A., & Poli, G. (1996) · Biochemical and Biophysical Research Communications
Fatty Acid Research and HealthInflammatory mediators and NSAID effects
Cited by 188
- Verified
Strictly Target Cell-dependent Activation of T Cells by Bispecific Single-chain Antibody Constructs of the BiTE Class
Brischwein, K., Parr, L., Pflanz, S., Volkland, J., Lumsden, J., Klinger, M., Locher, M., Hammond, S. A., Kiener, P., Kufer, P., et al. (2007) · Journal of Immunotherapy
Monoclonal and Polyclonal Antibodies ResearchT-cell and B-cell Immunology
Cited by 187
- Verified
T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells
Lutterbuese, R., Raum, T., Kischel, R., Hoffmann, P., Mangold, S., Rattel, B., Friedrich, M., Thomas, O., Lorenczewski, G., Rau, D., et al. (2010) · Proceedings of the National Academy of Sciences
Monoclonal and Polyclonal Antibodies ResearchColorectal Cancer Treatments and Studies
Cited by 166
- Verified
A revival of bispecific antibodies
Kufer, P., Lutterbüse, R., & Baeuerle, P. A. (2004) · Trends in Biotechnology
Monoclonal and Polyclonal Antibodies ResearchToxin Mechanisms and Immunotoxins
Cited by 157
- Verified
Eradication of Tumors from a Human Colon Cancer Cell Line and from Ovarian Cancer Metastases in Immunodeficient Mice by a Single-Chain Ep-CAM-/CD3-Bispecific Antibody Construct
Schlereth, B., Fichtner, I., Lorenczewski, G., Kleindienst, P., Brischwein, K., da Silva, A., Kufer, P., Lutterbuese, R., Junghahn, I., Kasimir-Bauer, S., et al. (2005) · Cancer Research
Monoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses
Cited by 132
- Verified
T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct
Schlereth, B., Quadt, C., Dreier, T., Kufer, P., Lorenczewski, G., Prang, N., Brandl, C., Lippold, S., Cobb, K., Brasky, K., et al. (2006) · Cancer Immunology, Immunotherapy
Monoclonal and Polyclonal Antibodies ResearchT-cell and B-cell Immunology
Cited by 103
- Verified
Therapeutic Window of MuS110, a Single-Chain Antibody Construct Bispecific for Murine EpCAM and Murine CD3
Amann, M., Brischwein, K., Lutterbuese, P., Parr, L., Petersen, L., Lorenczewski, G., Krinner, E., Bruckmeier, S., Lippold, S., Kischel, R., et al. (2008) · Cancer Research
Monoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses
Cited by 90
- Verified
Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells
Herrmann, I., Baeuerle, P. A., Friedrich, M., Murr, A., Filusch, S., Rüttinger, D., Majdoub, M. W., Sharma, S., Kufer, P., Raum, T., et al. (2010) · PLoS ONE
Cancer Cells and MetastasisImmunotherapy and Immune Responses
Cited by 85
- Verified
Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA
Lutterbuese, R., Raum, T., Kischel, R., Lutterbuese, P., Schlereth, B., Schaller, E., Mangold, S., Rau, D., Meier, P., Kiener, P. A., et al. (2009) · Journal of Immunotherapy
Monoclonal and Polyclonal Antibodies ResearchToxin Mechanisms and Immunotoxins
Cited by 77
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free